SynthesisPloS one2014

Ranibizumab versus bevacizumab for ophthalmic diseases related to neovascularisation: a meta-analysis of randomised controlled trials.

Bin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.